PDB Search results for query - 日本蛋白質結構資料庫

PDB: 887 results

MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
Descriptor:	IGG1-KAPPA DB3 FAB (HEAVY CHAIN), IGG1-KAPPA DB3 FAB (LIGHT CHAIN), PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE
Authors:	Arevalo, J.H, Wilson, I.A.
Deposit date:	1993-08-24
Release date:	1994-01-31
Last modified:	2024-06-05
Method:	X-RAY DIFFRACTION (2.7 Å)
Cite:	Molecular basis of crossreactivity and the limits of antibody-antigen complementarity. Nature, 365, 1993

8CWV

Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 2-31 and a human antibody CC12.1 Fab
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, CC12.1 Fab heavy chain, CC12.1 Fab light chain, ...
Authors:	Liu, H, Wilson, I.A.
Deposit date:	2022-05-19
Release date:	2022-07-06
Last modified:	2023-10-18
Method:	X-RAY DIFFRACTION (2.51 Å)
Cite:	Superimmunity by pan-sarbecovirus nanobodies. Cell Rep, 39, 2022

8CWU

Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 1-21
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, Spike protein S1, VHH 1-21
Authors:	Liu, H, Wilson, I.A.
Deposit date:	2022-05-19
Release date:	2022-07-06
Last modified:	2023-10-18
Method:	X-RAY DIFFRACTION (1.71 Å)
Cite:	Superimmunity by pan-sarbecovirus nanobodies. Cell Rep, 39, 2022

8D36

Crystal structure of SARS-CoV-2 fusion peptide in complex with neutralizing antibody COV44-62
Descriptor:	Neutralizing antibody COV44-62 heavy chain, Neutralizing antibody COV44-62 light chain, Spike protein S2 fusion peptide
Authors:	Yuan, M, Lee, C.C.D, Wilson, I.A.
Deposit date:	2022-05-31
Release date:	2022-07-27
Last modified:	2023-10-18
Method:	X-RAY DIFFRACTION (1.45 Å)
Cite:	Broadly neutralizing antibodies target the coronavirus fusion peptide. Science, 377, 2022

8DAO

Crystal structure of SARS-CoV-2 spike stem fusion peptide in complex with neutralizing antibody COV44-79
Descriptor:	COV44-79 heavy chain constant domain, COV44-79 heavy chain variable domain, COV44-79 light chain constant domain, ...
Authors:	Lin, T.H, Lee, C.C.D, Yuan, M, Wilson, I.A.
Deposit date:	2022-06-13
Release date:	2022-07-27
Last modified:	2023-10-18
Method:	X-RAY DIFFRACTION (2.8 Å)
Cite:	Broadly neutralizing antibodies target the coronavirus fusion peptide. Science, 377, 2022

8D6Z

Crystal structure of SARS-CoV-2 spike stem fusion peptide in complex with neutralizing antibody COV91-27
Descriptor:	Neutralizing antibody COV91-27 heavy chain, Neutralizing antibody COV91-27 light chain, Spike protein S2 fusion peptide
Authors:	Lee, C.C.D, Lin, T.H, Yuan, M, Wilson, I.A.
Deposit date:	2022-06-06
Release date:	2022-07-27
Last modified:	2023-10-18
Method:	X-RAY DIFFRACTION (2.3 Å)
Cite:	Broadly neutralizing antibodies target the coronavirus fusion peptide. Science, 377, 2022

1DBJ

MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
Descriptor:	AETIOCHOLANOLONE, IGG1-KAPPA DB3 FAB (HEAVY CHAIN), IGG1-KAPPA DB3 FAB (LIGHT CHAIN)
Authors:	Arevalo, J.H, Wilson, I.A.
Deposit date:	1993-08-24
Release date:	1994-01-31
Last modified:	2024-06-05
Method:	X-RAY DIFFRACTION (2.7 Å)
Cite:	Molecular basis of crossreactivity and the limits of antibody-antigen complementarity. Nature, 365, 1993

8DGX

Crystal structure of MERS-CoV spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC68.109 isolated from a vaccinated COVID-19 convalescent
Descriptor:	Antibody CC68.109 Fab heavy chain, Antibody CC68.109 Fab light chain, Spike protein S2'
Authors:	Liu, H, Wilson, I.A.
Deposit date:	2022-06-24
Release date:	2023-01-25
Last modified:	2023-10-25
Method:	X-RAY DIFFRACTION (2.89 Å)
Cite:	Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease. Immunity, 56, 2023

8DGU

Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC25.106 isolated from a vaccinated COVID-19 convalescent
Descriptor:	Antibody CC25.106 Fab heavy chain, Antibody CC25.106 Fab light chain, GLYCEROL, ...
Authors:	Liu, H, Wilson, I.A.
Deposit date:	2022-06-24
Release date:	2023-01-25
Last modified:	2023-10-25
Method:	X-RAY DIFFRACTION (1.89 Å)
Cite:	Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease. Immunity, 56, 2023

8DGV

Crystal structure of MERS-CoV spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC99.103 isolated from a vaccinated COVID-19 convalescent
Descriptor:	Antibody CC99.103 Fab heavy chain, Antibody CC99.103 Fab light chain, Spike protein S2'
Authors:	Liu, H, Wilson, I.A.
Deposit date:	2022-06-24
Release date:	2023-01-25
Last modified:	2023-10-25
Method:	X-RAY DIFFRACTION (2.3 Å)
Cite:	Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease. Immunity, 56, 2023

8DGW

Crystal structure of HCoV-HKU1 spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC95.108 isolated from a vaccinated COVID-19 convalescent
Descriptor:	Antibody CC95.108 Fab heavy chain, Antibody CC95.108 Fab light chain, Spike protein S2'
Authors:	Liu, H, Wilson, I.A.
Deposit date:	2022-06-24
Release date:	2023-01-25
Last modified:	2023-10-25
Method:	X-RAY DIFFRACTION (2.81 Å)
Cite:	Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease. Immunity, 56, 2023

8D0Y

Crystal Structure of HIV-1 BG505 SOSIPv8 Trimer in Complex with CD4bs targeting antibody 21N13 and interface targeting antibody 35O22 at 4.7 Angstrom
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 35O22scFv Heavy Chain Variable, ...
Authors:	Xian, Y, Wilson, I.A.
Deposit date:	2022-05-26
Release date:	2023-07-19
Last modified:	2024-05-15
Method:	X-RAY DIFFRACTION (4.7 Å)
Cite:	The domain-swaped dimer of the HIV-1 CD4bs targeting antibody 21N13 To Be Published

8D4R

Crystal Structure of Mosaic HIV-1 Envelope (MosM3.2) in Complex with antibodies PGT124 and 35O22 at 3.8 Angstrom
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 35O22 Fab heavy chain, ...
Authors:	Xian, Y, Wilson, I.A.
Deposit date:	2022-06-02
Release date:	2023-12-13
Last modified:	2024-05-15
Method:	X-RAY DIFFRACTION (3.81 Å)
Cite:	The domain-swaped dimer of the HIV-1 CD4bs targeting antibody 21N13 To Be Published

8D50

Crystal Structure of Mosaic HIV-1 Envelope (MosM3.1) in Complex with antibodies PGT124 and 35O22 at 4.3 Angstrom
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 35O22 Fab heavy chain, ...
Authors:	Xian, Y, Wilson, I.A.
Deposit date:	2022-06-03
Release date:	2023-12-13
Last modified:	2024-05-15
Method:	X-RAY DIFFRACTION (4.32 Å)
Cite:	Structural and Antigenic Characterization of B Cell Mosaic Env Trimers To Be Published

8D01

The domain-swaped dimer of the HIV-1 CD4bs targeting antibody 21N13
Descriptor:	21N13 Fab heavy chain, 21N13 Fab light chain
Authors:	Xian, Y, Wilson, I.A.
Deposit date:	2022-05-25
Release date:	2023-12-13
Last modified:	2024-05-15
Method:	X-RAY DIFFRACTION (2.46 Å)
Cite:	Structural and Antigenic Characterization of B Cell Mosaic Env Trimers To Be Published

2CKB

STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
Descriptor:	ALPHA, BETA T CELL RECEPTOR, BETA-2 MICROGLOBULIN, ...
Authors:	Garcia, K.C, Degano, M, Wilson, I.A.
Deposit date:	1998-01-14
Release date:	1998-04-29
Last modified:	2023-08-09
Method:	X-RAY DIFFRACTION (3 Å)
Cite:	Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science, 279, 1998

1FRG

CRYSTAL STRUCTURE, SEQUENCE, AND EPITOPE MAPPING OF A PEPTIDE COMPLEX OF AN ANTI-INFLUENZA HA PEPTIDE ANTIBODY FAB 26(SLASH)9: FINE-TUNING ANTIBODY SPECIFICITY
Descriptor:	IGG2A 26/9 FAB (HEAVY CHAIN), IGG2A 26/9 FAB (LIGHT CHAIN), INFLUENZA HEMAGGLUTININ HA1 (STRAIN X47) (RESIDUES 101 - 108)
Authors:	Churchill, M.E.A, Wilson, I.A.
Deposit date:	1994-01-17
Release date:	1994-05-31
Last modified:	2024-06-05
Method:	X-RAY DIFFRACTION (2.8 Å)
Cite:	Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen. J.Mol.Biol., 241, 1994

2FX9

Crystal structure of hiv-1 neutralizing human fab 4e10 in complex with a thioether-linked peptide encompassing the 4e10 epitope on gp41
Descriptor:	Fab 4E10, Fragment of HIV glycoprotein gp41
Authors:	Cardoso, R.M.F, Brunel, F.M, Ferguson, S, Burton, D.R, Dawson, P.E, Wilson, I.A.
Deposit date:	2006-02-03
Release date:	2006-12-19
Last modified:	2023-08-30
Method:	X-RAY DIFFRACTION (2.1 Å)
Cite:	Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10. J.Mol.Biol., 365, 2007

4ZCJ

Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin HA1 Cys30, HA2 Cys47 mutant
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Hemagglutinin, ...
Authors:	Lee, P.S, Wilson, I.A.
Deposit date:	2015-04-16
Release date:	2015-05-13
Last modified:	2023-09-27
Method:	X-RAY DIFFRACTION (3 Å)
Cite:	Design and Structure of an Engineered Disulfide-Stabilized Influenza Virus Hemagglutinin Trimer. J.Virol., 89, 2015

1A3L

CATALYSIS OF A DISFAVORED REACTION: AN ANTIBODY EXO DIELS-ALDERASE-TSA-INHIBITOR COMPLEX AT 1.95 A RESOLUTION
Descriptor:	1-CARBOXY-1'-[(DIMETHYLAMINO)-CARBONYL]FERROCENE, IMMUNOGLOBULIN FAB 13G5 (HEAVY CHAIN), IMMUNOGLOBULIN FAB 13G5 (LIGHT CHAIN)
Authors:	Heine, A, Wilson, I.A.
Deposit date:	1998-01-22
Release date:	1999-02-16
Last modified:	2023-08-02
Method:	X-RAY DIFFRACTION (1.95 Å)
Cite:	An antibody exo Diels-Alderase inhibitor complex at 1.95 angstrom resolution. Science, 279, 1998

1AXT

IMMUNE VERSUS NATURAL SELECTION: ANTIBODY ALDOLASES WITH THE RATES OF NATURAL ENZYMES
Descriptor:	IMMUNOGLOBULIN IGG2A
Authors:	Heine, A, Wilson, I.A.
Deposit date:	1997-10-20
Release date:	1998-10-28
Last modified:	2023-08-02
Method:	X-RAY DIFFRACTION (2.15 Å)
Cite:	Immune versus natural selection: antibody aldolases with enzymic rates but broader scope. Science, 278, 1997

5AWN

Crystal structure of Human anti-HIV-1 broadly neutralizing antibody 3BC176 Fab
Descriptor:	Heavy chain of 3BC176 Fab, Light chain of 3BC176 Fab
Authors:	Lee, J.H, Wilson, I.A, Ward, A.B.
Deposit date:	2015-07-06
Release date:	2015-11-11
Last modified:	2023-11-08
Method:	X-RAY DIFFRACTION (1.887 Å)
Cite:	Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike. Nat Commun, 6, 2015

5BZD

Crystal Structure of PCDN-27A, an antibody from the PCDN family of HIV-1 antibodies
Descriptor:	5G8 HIV Antibody heavy chain, 5G8 HIV Antibody light chain, GLYCEROL
Authors:	Garces, F, WILSON, I.A.
Deposit date:	2015-06-11
Release date:	2016-05-25
Last modified:	2023-09-27
Method:	X-RAY DIFFRACTION (2.7 Å)
Cite:	Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch Immunity, 44, 2016

5BZW

Crystal Structure of PCDN-27B, an antibody from the PCDN family of HIV-1 antibodies
Descriptor:	2-acetamido-2-deoxy-beta-D-glucopyranose, 2B3 HIV Antibody heavy chain, 2B3 HIV Antibody light chain, ...
Authors:	Garces, F, WILSON, I.A.
Deposit date:	2015-06-11
Release date:	2016-05-25
Last modified:	2023-09-27
Method:	X-RAY DIFFRACTION (2.9 Å)
Cite:	Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch. Immunity, 44, 2016

1C1E

CRYSTAL STRUCTURE OF A DIELS-ALDERASE CATALYTIC ANTIBODY 1E9 IN COMPLEX WITH ITS HAPTEN
Descriptor:	1,7,8,9,10,10-HEXACHLORO-4-METHYL-4-AZA-TRICYCLO[5.2.1.0(2,6)]DEC-8-ENE-3,5-DIONE, CATALYTIC ANTIBODY 1E9 (HEAVY CHAIN), CATALYTIC ANTIBODY 1E9 (LIGHT CHAIN), ...
Authors:	Xu, J, Wilson, I.A.
Deposit date:	1999-07-22
Release date:	2000-03-01
Last modified:	2013-01-30
Method:	X-RAY DIFFRACTION (1.9 Å)
Cite:	Evolution of shape complementarity and catalytic efficiency from a primordial antibody template. Science, 286, 1999

<9 10 11 12 13 14 151617 18 19 20 21 22 23 24 >

Total results:	887
Displayed results:	25
Sorted by:	Hit score (from highest)
Deposition authors:	"WIlson, I.A."